Lymphatic muscle contraction is critical for the centripetal movement of lymph that regulates fluid balance, protein homeostasis, lipid absorption and immune function. We have demonstrated that lymphatic muscle has both smooth and striated muscle contractile elements; however, the basic contractile properties of this tissue remain poorly defined.
Introduction
The lymphatic vascular system plays an important role in fluid and protein homeostasis, lipid absorption and immune function (47) . Lymphatic transport of fluids, macromolecules and immune cells from the peripheral tissues to the blood vascular system occurs against a net pressure gradient. Thus, lymph transport relies on a system of lymph pumps and valves to drive and direct lymph flow. Impairment of the lymph pump has been documented in several pathological conditions, such as aging (13), inflammatory bowel disease (45) and in women following lymph node resection to treat breast cancer (32) , and is associated with lymphedema and an increased risk of infection in the affected region (28, 36) . Despite its critical role in health and disease, relatively little is known about basic contractile properties of lymphatic muscle (47) . Lymphatic muscle is a highly specialized type of smooth muscle that exhibits both tonic and phasic contractions that are responsible for the distinct periods of diastole and systole, respectively, observed in collecting lymphatics. Both tonic and phasic contractions are sensitive to changes in pressure and flow (11, 12) , extracellular Ca2+ concentration (29) , and agonist stimulation (1, 2) . The phasic contractions in rat Page 3 of 33 mesenteric lymphatics occur at frequencies of ~5-15 contractions per minute (48) .
Interestingly, the shortening velocity of lymphatic muscle has been reported to be ~2-and ~5-fold faster than that of phasic and tonic smooth muscle, respectively, and closer to that of striated muscle (3) . In support of the unique functional behavior of lymphatic muscle, we have recently reported that the lymphatic muscle contractile protein (i.e. actin and myosin) expression profile is composed of both cardiac/skeletal and smooth muscle isoforms (33). Our results demonstrated that rat mesenteric lymphatics express only SMB smooth muscle myosin heavy chain (SM-MHC), whereas, nearby mesenteric arterioles expressed both SMA and SMB isoforms. In addition, slow-skeletal/fetal cardiac muscle-specific -MHC message was detected only in mesenteric lymphatics.
Furthermore, all four actin messages, -cardiac, -vascular, -enteric and -skeletal, were present in both mesenteric lymphatics and arterioles. Western blot and immunohistochemical analyses corroborated the mRNA studies with the exception that only -vascular actin protein was detected in arterioles. This combination of smooth and striated muscle contractile elements present in lymphatic muscle could provide unique contractile characteristics (i.e. Ca 2+ sensitivity and cooperativity) for lymphatic myofilaments. Although numerous mechanical (3, 12, 30, 35, 49) and neurohumoral (1, 2, 19, 31, 46, 50) factors have been shown to modulate the tonic and phasic activity of collecting lymphatics, few investigations of the basic contractile properties of the lymphatic myofilament have been published.
Smooth muscle is generally classified as either tonic or phasic based on its contractile behavior (38) . Regulation of smooth muscle contraction occurs primarily through the phosphorylation of the 20kD regulatory myosin light chain (MLC 20 ), which is sensitive to the relative activities of MLC kinase (MLCK) and MLC phosphatase (MLCP) (37) . A number of published reports have indicated that significant differences exist between the molecular composition and the contractility of myofilaments from tonic and phasic smooth muscle. For example, phasic smooth muscle expresses higher levels of the acidic 17 kD myosin light chain isoform (39), the MLCP regulatory subunit, MYPT1, (44) and the thin filament proteins caldesmon and calmodulin (40) . Reports indicate that both MLCK and MLCP activities are higher in phasic compared to tonic smooth Page 4 of 33 muscle (15, 40) . On the other hand, tonic smooth muscle expresses higher levels of the calcium-sensitizing protein, CPI-17, which is a potent inhibitor of MLCP when activated via phosphorylation of Thr38 (17) . In addition to the molecular differences between tonic and phasic smooth muscle myofilaments, tonic vascular smooth muscle treated with the mild permeabilizing agent, -toxin, has been shown to exhibit significantly greater Ca 2+ sensitivity than does phasic vascular and visceral smooth muscle (24) .
Although detailed comparisons have been made between the myofilaments from tonic and phasic smooth muscle from different organ systems, no such data is available for lymphatic muscle, which exhibits both tonic and phasic activities.
In recent studies characterizing the mechanical properties of lymphatic muscle, we have shown that mesenteric lymphatic muscle exhibits striking contractile differences when compared with small arteries and veins from the same vascular bed.
Though lymphatic vessels generate the least active tension and stress among these three vessels, the lymphatic vessels exhibited distinct elastic characteristics as well as both phasic and tonic contractions (4, 48, 49) . Since tonic and phasic smooth muscle myofilaments exhibit different biochemical characteristics and the lymphatic muscle has unique biomechanical properties, we hypothesized that the calcium sensitivity and cooperativity of lymphatic myofilaments must be different from tonic vascular smooth muscle in order to attain its unique phasic and tonic contractile nature. To test this hypothesis, we determined the calcium-tension relationship in permeabilized mesenteric lymphatic segments and compared it with the calcium-tension relationships of permeabilized mesenteric arteries and veins.
The use of permeabilized smooth muscle preparations provides important information regarding basic biochemical properties, such as calcium sensitivity (pCa 50 ) and cooperativity (n H ) of contraction at the myofilament level. There are several methods frequently used to permeabilize or skin smooth muscle; these include -toxin, -escin, saponin and Triton X-100. Treatment with -toxin or -escin results in permeabilized membranes that maintain receptor-coupled signaling pathways (25, 27) that are disrupted after treatment with saponin or Triton X-100. For this reason, -toxin However, the size of the pores created by -toxin and -escin differs substantially.
Permeabilization with -toxin results in the formation of small transmembrane pores that allow the passage of ions and small molecules but limits the movement of large molecules (8), whereas -escin creates larger pores that allow passage of ions, small and larger molecules across the permeabilized membrane (21) . Because of the advantages and disadvantages inherent to the different permeabilization methods and the conflicting reports regarding the effects of permeabilization treatment on smooth muscle contractility (41, 42) , we also determined the effects of two types of permeabilization ( -toxin and -escin) on the calcium-tension relationship of permeabilized lymphatic muscle. Length-tension protocol. A vessel segment was mounted in the myograph and the bathing solution was maintained at 25°C. The experimental protocols were initiated after a 30-60 min equilibration period during which the bathing solution was changed once. We first attested the length-activated tension relationship of each vessel as described previously (49) . Briefly, vessels were stretched to a range of predetermined preloads. After a steady preload was achieved, vessels were maximally activated with KPSS (PSS with equimolar substitution of KCl for NaCl). For the experiments with mesenteric lymphatics and veins, the KPSS was supplemented with 1 µM Substance P (SP; KPSS+SP). The optimal circumferential length (L 0 ) was defined as the internal circumference that resulted in the greatest peak active tension. After L 0 was determined, the vessel was set to the optimal length (L 0 ), force was allowed to stabilize in PSS, then the vessel was incubated in a high relaxing (HR) solution for 10-20 min before permeabilization.
Materials and Methods

Animals
Solutions. The HR and pCa solutions used during and following permeabilization of the mesenteric vessels were designed to maintain a desired free Ca An independent sample t-test was used to determine differences in maximal tension, pCa 50 and n H between -toxin and -escin permeabilized lymphatics, and betweentoxin permeabilized lymphatics and arteries or veins. Significance was set at p<0.05.
Results
The results of the length-tension and pCa-tension protocols for mesenteric lymphatics, arteries and veins are summarized in Table 1 . Initially, length-tension relationships were determined prior to the permeabilization procedure in lymphatic vessels. Approximately 80% of the mesenteric lymphatics developed spontaneous phasic contractions at various preloads during assessment of length-tension relations.
In those lymphatics that exhibited phasic activity, the force during the relaxation phase of the contraction cycle was used to determine the preload. As described previously (49) , mesenteric lymphatics, as well as mesenteric veins, exhibited a biphasic response to maximal activation with KPSS+SP. Figure 1 depicts the length-tension relationship for the peak response of activated mesenteric lymphatics. The maximal peak and plateau active tension was 0.38±0.02 and 0.20±0.02 mN/mm, respectively, and occurred at a preload of 0.09±0.00 mN/mm, which corresponds to a calculated internal pressure of ~17 cmH 2 O. This is a higher pressure than might be expected based on in vivo or in vitro isobaric preparations that suggest mesenteric lymphatic pumping peaks at ~5 cmH 2 O (11), but this phenomenon is fairly consistent with other investigations that have used an isometric preparation to study rat mesenteric lymphatic contractility (48, 49) . The slightly higher calculated internal pressure associated with L 0 in the current study and that observed previously might be due to the effects of temperature on the mechanical properties in the vessel wall (16), since the present experiments were performed at 25°C while the earlier studies were performed at ~37°C (11, 48, 49) . The plateau phase of the active tension response in mesenteric lymphatics averaged 58±2.5% of the maximal peak active tension and was well maintained over a wide range of preloads (data not shown).
After determining L 0 , mesenteric lymphatics were permeabilized with eithertoxin or -escin. Following -toxin permeabilization, mesenteric lymphatics exhibited a biphasic time course of force development in response to a given pCa solution ( Figure   2A ), which was similar to the response to KPSS+SP demonstrated by intact mesenteric lymphatics (49) . In contrast, -escin permeabilized mesenteric lymphatics displayed a monophasic force response to an increase in calcium ( Figure 2B ). The maximal peak and plateau tension produced by -toxin-permeabilized mesenteric lymphatics in pCa 4.5 was 0.47±0.04 and 0.27±0.03 mN/mm, respectively ( Figure 3A ). Non-linear regression analysis of the normalized pCa-tension relationship revealed the pCa 50 Figure 3B and Table 1 ). We used the pCa 50 and n H values obtained from the pCa-plateau tension relationship of lymphatics to compare with -escin permeabilized lymphatics or -toxin permeabilized artery or veins.
-escin permeabilization of lymphatic muscle was associated with significantly lower plateau tension development in pCa 4.5 when compared with -toxin treated lymphatics (0.15±0.01 vs. 0.27±0.03 mN/mm, respectively; p<0.05; Figure 4 and Table   1 ). Therefore, relative to the plateau active tension produced by intact lymphatics at L 0 , the maximal tension in pCa 4.5 produced by -toxin and -escin permeabilized mesenteric lymphatics was ~135% and ~75%, respectively. The normalized pCatension relationship revealed that the pCa 50 of -toxin permeabilized mesenteric lymphatics was significantly higher compared to that of lymphatics permeabilized with - phosphorylation is regulated by the relative activity of MLC kinase (MLCK) and MLC phosphatase (MLCP); and the activity of MLCK and MLCP is modulated by the small molecular weight proteins, calmodulin (CaM; MW=17 kD) and CPI-17 (MW=17 kD), respectively (37) . Loss of CaM (27) and CPI-17 (26) has been implicated in the depressed contractile response of skinned or stringently permeabilized smooth muscle.
To determine whether the decreases in maximal tension and Ca 2+ sensitivity following -escin permeabilization were associated with leakage of CaM and/or CPI-17 from lymphatic muscle, Western blotting was performed on intact, -toxin and -escin permeabilized mesenteric lymphatics. As shown in Figure 5 , CaM levels were not significantly altered following either permeabilization treatment relative to controls. In contrast, permeabilization of lymphatics with -escin resulted in an ~50% decrease in CPI-17 levels compared to intact controls (p<0.05; n=5-6).
Since this is the first description of the pCa-tension relationship in permeabilized lymphatic muscle, for comparison we performed length-tension and pCa-tension experiments in intact and permeabilized mesenteric arteries and veins that lie adjacent to lymphatics. The maximal active tension produced by intact mesenteric arteries was 2.52±0.15 mN/mm and occurred at a preload of 0.76±0.14 mN/mm, which corresponded to a calculated internal pressure of 63.1±8.86 cmH 2 O. Not surprisingly, the maximal peak active tension produced by mesenteric veins was considerably less than mesenteric arteries (0.63±0.07 mN/mm). The preload at which the maximal response was obtained was 0.25±0.00 mN/mm, which corresponded to a calculated internal pressure of 31.3±1.6 cmH 2 O. The pCa-tension relationships for -toxin permeabilized mesenteric arterial and venous smooth muscle are presented in Figure 6 .
As was observed in lymphatic muscle, both arterial and venous segments generated maximal tensions during pCa 4.5 activation following permeabilization with -toxin that were similar to the tensions produced by the intact vessels at L 0 ( Table 1) . The pCa 50 of -toxin permeabilized mesentery arteries was significantly left-shifted in comparison to the calcium sensitivity of -toxin treated lymphatic muscle (6.44±0.02 vs. 6.16±0.05; p<0.05; Figure 6A and Table 1 ). In contrast, the pCa 50 of -toxin permeabilized venous smooth muscle was not significantly different than -toxin permeabilized lymphatic muscle (6.00±0.10 vs. 6.16±0.05; p=0.12; Figure 6B and Table 1 ). These data indicated that the calcium sensitivity of phasic lymphatic muscle is lower than that of tonic arterial smooth muscle, but similar to that of venous smooth muscle. The Hill coefficient (n H ), which represents myofilament cooperativity, was significantly higher in lymphatic muscle compared to venous smooth muscle (1.98±0.19 vs. 1.21±0.18; p<0.05; Figure 6B and Table 1 ), but no significant difference was detected between lymphatic and arterial smooth muscle (1.98±0.19 vs. 1.86±0.10; n.s.; Figure 6A and Table 1 ).
Discussion
The results presented here are the first demonstration of the pCa-tension relationship in permeabilized lymphatic muscle and, therefore, represent the first detailed investigation of the contractility of the lymphatic myofilament. The data demonstrate that the lymphatic myofilament has contractile characteristics that are unique to this tissue as indicated by the differences in the calcium sensitivity and cooperative activation when compared to arterial and venous myofilaments, respectively, following the same permeabilization treatment. Furthermore, our results demonstrate that the differences in the lymphatic myofilament contractile behavior following two types of permeabilization are related to the loss of a key protein, CPI-17, that modulates contractility.
Our results support the hypothesis that the contractile properties of permeabilized phasic lymphatic muscle differ from that of tonic vascular smooth muscle.
The Ca 2+ sensitivity of permeabilized phasic lymphatic muscle is approximately two-fold lower than that of tonic arterial smooth muscle ( Figure 6 and Table 1 ). These findings are similar to those of Kitazawa et al. (24) who reported that the Ca 2+ sensitivity oftoxin permeabilized phasic vascular (portal vein) and visceral (ileum) smooth muscle is significantly lower that that of tonic arterial smooth muscle. Furthermore, the Ca 2+ sensitivity of -toxin permeabilized mesenteric arterial smooth muscle (Table 1) is strikingly similar to that reported for pulmonary and femoral arteries in a previous study (24) . Although the pCa 50 values of permeabilized lymphatic and venous myofilaments are not significantly different, our data show that the Hill coefficient is significantly greater for the pCa-tension relationship of lymphatic muscle compared to venous smooth muscle. These data indicate that cooperativity among lymphatic myofilament proteins is higher than that in venous smooth muscle. The presented data indicate that the Ca
2+
-dependent and -independent activation mechanisms of the lymphatic myofilament are distinct from arterial and venous smooth muscle, respectively, which likely underlie important functional differences between these tissues.
Although not measured in the current study, we and others have shown that skinned cardiac muscle generally exhibits a pCa 50 close to ~5.8 and a n H close to ~3.0 (9) . Thus, the characteristics of -toxin permeabilized lymphatic muscle are in between that of striated and smooth muscle myofilaments. Specifically, the pCa 50 value of tonic vascular smooth muscle myofilaments is greater than that of lymphatic myofilaments, which is greater than that of cardiac myofilaments (6.44±0.02 > 6.16±0.05 > 5.83±0.02, respectively). However, it should be noted that the pCa 50 and n H of -escin permeabilized lymphatics was similar to those values normally associated with cardiac muscle (Table 1) . These findings are difficult to interpret because a complete characterization of the regulatory proteins associated with the lymphatic myofilament has not been performed. Although we have previously shown that both smooth and striated muscle myosin and actin isoforms are present in lymphatic muscle (33), whether the lymphatic myofilament encompasses regulatory mechanisms ascribed to smooth and striated muscle is an important question, but beyond the scope of the current investigation. However, the results of the present experiments do provide a basis for understanding the molecular mechanisms that regulate lymphatic muscle contraction.
In addition to comparing the pCa-tension relationships between -toxin permeabilized lymphatics and vascular smooth muscle, we also compared the effects of different permeabilization methods on the pCa-tension relationship in lymphatic muscle.
Our results indicate that permeabilization of mesenteric lymphatic muscle with -toxin and -escin resulted in striking differences in the contractile response to Ca following permeabilization with -toxin (biphasic) compared to a monophasic response after permeabilization with -escin (27) or saponin (25) .
However, in contrast to the work of Kitazawa et al. (25) , the Ca 2+ sensitivity associated with the peak response was not greater than the plateau response in -toxin permeabilized lymphatic muscle, thus indicating a subtle difference in the behavior oftoxin permeabilized phasic ileum and lymphatic muscle.
In addition to the altered magnitude and temporal pattern of the contractile response to an increase in Ca
, the pCa-tension relationship of permeabilized lymphatic muscle was greatly affected by the method of permeabilization. As presented in Table 1 and Figure 4 , -toxin permeabilized mesenteric lymphatics exhibited greater maximal tension and calcium sensitivity than did -escin permeabilized lymphatics, whereas myofilament cooperativity was greater following -escin permeabilization of lymphatic muscle. Our findings differ from those of Watanabe et al. (42) 
Perspectives and significance
Our data demonstrate that the pCa-tension relationship of permeabilized phasic lymphatic muscle is different from those of tonic vascular smooth muscle. We postulate that the fundamental differences in myofilament activation between these tissues contribute to their specialized functions in regulating blood pressure (arteries) and volume (veins) and in the generation and regulation of lymph flow (lymphatics). In addition, we provide indirect evidence that CPI-17-dependent inhibition of MLCP is an important regulatory mechanism of lymphatic muscle contraction and Ca 2+ sensitivity.
The use of these permeabilized lymphatic muscle preparations will accelerate our understanding of the unique contractile properties of this tissue. Furthermore, these types of experiments will allow us to determine whether alterations in the lymphatic myofilament contribute to impaired function of the lymph pump in disease conditions such as chronic edema. active tension ( ) was calculated as the difference between total and passive tension.
Error bars are ± SEM; n=12. 
